Sharda Cropchem Intrinsic Value
SHARDACROP • Chemicals
Current Stock Price
₹870.10
Primary Intrinsic Value
₹395.52
Market Cap
₹7831 Cr
-54.5%
Downside
Median Value
₹395.52
Value Range
₹261 - ₹912
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%
SHARDACROP Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹395.52 | ₹316.42 - ₹474.62 | -54.5% | EPS: ₹32.96, Sector P/E: 12x |
| Book Value Method | asset | ₹277.89 | ₹250.10 - ₹305.68 | -68.1% | Book Value/Share: ₹277.89, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹340.98 | ₹306.88 - ₹375.08 | -60.8% | Revenue/Share: ₹426.22, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹432.00 | ₹388.80 - ₹475.20 | -50.4% | EBITDA: ₹648.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹911.59 | ₹729.27 - ₹1093.91 | +4.8% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹261.03 | ₹234.93 - ₹287.13 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹271.59 | ₹244.43 - ₹298.75 | -68.8% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹435.05 | ₹391.55 - ₹478.56 | -50.0% | ROE: 11.8%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹453.96 | ₹408.56 - ₹499.36 | -47.8% | EPS: ₹32.96, BVPS: ₹277.89 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
SHARDACROP Intrinsic Value Analysis
What is the intrinsic value of SHARDACROP?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Sharda Cropchem (SHARDACROP) is ₹395.52 (median value). With the current market price of ₹870.10, this represents a -54.5% variance from our estimated fair value.
The valuation range spans from ₹261.03 to ₹911.59, indicating ₹261.03 - ₹911.59.
Is SHARDACROP undervalued or overvalued?
Based on our multi-method analysis, Sharda Cropchem (SHARDACROP) appears to be trading above calculated value by approximately 54.5%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 15.07 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 11.8% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 14.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.81x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Sharda Cropchem
Additional stock information and data for SHARDACROP
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹604 Cr | ₹356 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹341 Cr | ₹145 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹328 Cr | ₹272 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹267 Cr | ₹165 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹246 Cr | ₹105 Cr | Positive Free Cash Flow | 7/10 |